ATOS - Atossa Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Atossa Therapeutics, Inc.
Atossa Genetics Inc mainly focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
IPO Date: November 8, 2012
Sector: Healthcare
Industry: Biotech
Market Cap: $25.35M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.11 | 5.23%
Avg Daily Range (30 D): $0.11 | 4.44%
Avg Daily Range (90 D): $0.12 | 4.70%
Institutional Daily Volume
Avg Daily Volume: 1.75M
Avg Daily Volume (30 D): .08M
Avg Daily Volume (90 D): .12M
Trade Size
Avg Trade Size (Sh.): 389
Avg Trade Size (Sh.) (30 D): 134
Avg Trade Size (Sh.) (90 D): 129
Institutional Trades
Total Institutional Trades: 168
Avg Institutional Trade: $2.14M
Avg Institutional Trade (30 D): $3.98M
Avg Institutional Trade (90 D): $3.98M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $5.33M
Avg Closing Trade (30 D): $9.36M
Avg Closing Trade (90 D): $9.36M
Avg Closing Volume: 106.53K
 
News
May 26, 2026 @ 5:00 PM
Duchenne Muscular Dystrophy Clinical Trial Pipelin...
Source: Delveinsight
May 8, 2026 @ 12:45 PM
Atossa Therapeutics Reports First Quarter 2026 Fin...
Source: Atossa Therapeutics Inc
Mar 19, 2026 @ 3:00 PM
The Patent Cliff is Coming, Driving Smart Money To...
Source: Equity-Insider.Com
Aug 28, 2025 @ 12:30 PM
Atossa Therapeutics CEO to Discuss Clinical Progre...
Source: Prnewswire
Oct 14, 2024 @ 9:08 PM
Atossa Therapeutics to Present at the 2024 Maxim H...
Source: N/A
Splits
Feb 02, 2026 1:15
Apr 20, 2018 1:12
Aug 26, 2016 1:15